Alpha Tau Medical Ltd.
DRTSNasdaq
$13.55
↑ +14.1%Jul 17 close · end-of-day
Price
1Y↑ +341.4%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$1.1B
Enterprise Value
$1.0B
P/E
—
P/S
—
P/B
14.2
EV/EBITDA
—
PEG
—
FCF Yield
-3.0%
Dividend Yield
—
Revenue (TTM)
—
Net Income (TTM)
-$42.6M
Free Cash Flow (TTM)
-$32.8M
Gross Margin
—
Operating Margin
—
Net Margin
—
ROE
-55.3%
ROIC
-840.9%
Debt / Equity
—
Net Cash
$73.1M
Return 1Y
+342.8%
Company profile
N/A
- CEO
- Uzi Sofer
- Sector
- Manufacturing
- Industry
- Medical Equipment
- Employees
- 80
- Website
- alphatau.com
Earnings
No reported earnings periods on file.
Financial statements
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — |
| Operating income | -$9.2M | -$13.8M | -$32.1M | -$35.7M | -$36.0M | -$42.3M |
| Net income | -$8.9M | -$27.3M | -$33.8M | -$29.2M | -$31.8M | -$42.6M |
| Diluted EPS | -$0.22 | -$0.67 | -$0.53 | -$0.42 | -$0.45 | -$0.53 |
| Operating cash flow | -$7.3M | -$11.8M | -$23.9M | -$18.0M | -$19.8M | -$26.7M |
| Free cash flow | -$11.0M | -$14.7M | -$24.8M | -$24.4M | -$22.0M | -$32.8M |
| Gross margin | — | — | — | — | — | — |
| Operating margin | — | — | — | — | — | — |
| Net margin | — | — | — | — | — | — |
No quarterly data.
Company news
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-07-06 | Levy Raphi· Chief Financial Officer | Sale | 2,270 | $14.00 | $31,782.50 | filing |
| 2026-07-06 | Levy Raphi· Chief Financial Officer | Option exercise | 2,270 | $2.98 | $6,764.60 | filing |
| 2026-07-02 | Levy Raphi· Chief Financial Officer | Sale | 17,873 | $13.00 | $232,397.26 | filing |
| 2026-07-02 | Levy Raphi· Chief Financial Officer | Option exercise | 17,873 | $2.98 | $53,261.54 | filing |
| 2026-07-01 | Levy Raphi· Chief Financial Officer | Sale | 2,127 | $13.02 | $27,691.20 | filing |
| 2026-07-01 | Levy Raphi· Chief Financial Officer | Option exercise | 2,127 | $2.98 | $6,338.46 | filing |
| 2026-06-30 | Levy Raphi· Chief Financial Officer | Sale | 20,000 | $12.00 | $240,044.00 | filing |
| 2026-06-25 | Levy Raphi· Chief Financial Officer | Sale | 15,778 | $11.00 | $173,561.16 | filing |
| 2026-06-25 | Levy Raphi· Chief Financial Officer | Sale | 4,222 | $11.00 | $46,442.84 | filing |
| 2026-06-23 | Levy Raphi· Chief Financial Officer | Sale | 15,000 | $9.47 | $142,050.00 | filing |
| 2026-06-23 | Levy Raphi· Chief Financial Officer | Sale | 2,500 | $10.00 | $25,001.00 | filing |
| 2026-06-03 | Levy Raphi· Chief Financial Officer | Sale | 17,500 | $10.90 | $190,758.75 | filing |
| 2026-06-03 | Levy Raphi· Chief Financial Officer | Sale | 15,000 | $10.76 | $161,356.50 | filing |
Latest 13 transactions.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.